Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

VRCA

Verrica Parmaceuticals (VRCA)

Verrica Parmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:VRCA
FechaHoraFuenteTítuloSímboloCompañía
15/05/202406:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRCAVerrica Parmaceuticals Inc
13/05/202415:31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VRCAVerrica Parmaceuticals Inc
13/05/202407:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VRCAVerrica Parmaceuticals Inc
29/02/202407:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VRCAVerrica Parmaceuticals Inc
16/11/202315:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
16/11/202309:28Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:VRCAVerrica Parmaceuticals Inc
15/11/202315:54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
21/07/202318:28Dow Jones NewsStocks to Watch: AMC Entertainment, Becton Dickinson and Verrica PharmaceuticalsNASDAQ:VRCAVerrica Parmaceuticals Inc
21/07/202316:05Dow Jones NewsVerrica Pharmaceuticals' Molluscum Contagiosum Topical Solution Gets FDA ApprovalNASDAQ:VRCAVerrica Parmaceuticals Inc
12/06/202308:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRCAVerrica Parmaceuticals Inc
08/06/202315:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRCAVerrica Parmaceuticals Inc
09/05/202307:28Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VRCAVerrica Parmaceuticals Inc
09/05/202307:22Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:VRCAVerrica Parmaceuticals Inc
21/04/202307:57Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VRCAVerrica Parmaceuticals Inc
21/04/202307:51Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:VRCAVerrica Parmaceuticals Inc
21/04/202307:46Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:VRCAVerrica Parmaceuticals Inc
06/03/202308:41Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VRCAVerrica Parmaceuticals Inc
22/02/202315:18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:VRCAVerrica Parmaceuticals Inc
14/02/202313:37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VRCAVerrica Parmaceuticals Inc
20/12/202205:10Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VRCAVerrica Parmaceuticals Inc
14/11/202205:15TipRanksH.C. Wainwright Remains a Buy on Verrica Pharmaceuticals (VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
10/11/202219:48TipRanksRBC Capital Remains a Hold on Verrica Pharmaceuticals (VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
07/11/202216:23Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:VRCAVerrica Parmaceuticals Inc
07/11/202215:05GlobeNewswire Inc.Verrica Pharmaceuticals Reports Third Quarter 2022 Financial ResultsNASDAQ:VRCAVerrica Parmaceuticals Inc
31/08/202215:30GlobeNewswire Inc.Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:VRCAVerrica Parmaceuticals Inc
12/08/202205:25TipRanksH.C. Wainwright Keeps Their Buy Rating on Verrica Pharmaceuticals (VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
11/08/202215:35TipRanksNeedham Remains a Hold on Verrica Pharmaceuticals (VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
11/08/202206:30GlobeNewswire Inc.Verrica Pharmaceuticals Reports Second Quarter 2022 Financial ResultsNASDAQ:VRCAVerrica Parmaceuticals Inc
05/08/202211:18PR Newswire (US)VRCA SHAREHOLDER ALERT: Jakubowitz Law Reminds Verrica Shareholders of a Lead Plaintiff Deadline of August 5, 2022NASDAQ:VRCAVerrica Parmaceuticals Inc
03/08/202204:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Verrica Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 5, 2022 - (NASDAQ: VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:VRCA